[1] COWLEY S M,HOARE S,MOSSELMAN S,et al.Estrogen receptors alpha and beta form heterodimers on DNA[J].J Biol Chem,1997,272(32):19858-19862.
[2] 封旭,蔡云朗,沈杨,等.雌激素受体亚型对妇科疾病影响的研究进展[J].东南大学学报:医学版,2013,32(5):651-654.
[3] 伍刚,刘策,周敬安,等.雌激素受体αPvuⅡ、XbaⅠ基因RFLP与脑动脉瘤相关性[J].现代医学,2014,42(8):884-887.
[4] LIU Y,GAO H,MARSTRAND T T,et al.The genome landscape of ERalpha- and ERbeta-binding DNA regions[J].Proc Natl Acad Sci,2008,105(7):2604-2609.
[5] ZHAO C,GAO H,LIU Y,et al.Genome-wide mapping of estrogen receptor-beta-binding regions reveals extensive cross-talk with transcription factor activator protein-1[J].Cancer Res,2010,70(12):5174-5183.
[6] GROBER O M,MUTARELLI M,GIURATO G,et al.Global analysis of estrogen receptor beta binding to breast cancer cell genome reveals an extensive interplay with estrogen receptor alpha for target gene regulation[J].BMC Genomics,2011,12:12-36.
[7] HURTADO A,HOLMES K A,ROSS-INNES C S,et al.FOXA1 is a key determinant of estrogen receptor function and endocrine response[J].Nat Genet,2011,43(1):27-33.
[8] CHANG E C,FRASOR J,KOMM B,et al.Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells[J].Endocrinology,2006,147(10):4831-4842.
[9] WILLIAMS C,EDVARDSSON K,LEWANDOWSKI S A,et al.A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells[J].Oncogene,2008,27(7):1019-1032.
[10] NASSA G,TARALLO R,GUZZI P H,et al.Comparative analysis of nuclear estrogen receptor alpha and beta interactomes in breast cancer cells[J].Mol Biosyst,2011,7(3):667-676.
[11] CIRILLO F,NASSA G,TARALLO R,et al.Molecular mechanisms of selective estrogen receptor modulator activity in human breast cancer cells:identification of novel nuclear cofactors of antiestrogen-ERalpha complexes by interaction proteomics[J].J Proteome Res,2013,12(1):421-431.
[12] HUANG B,OMOTO Y,IWASE H,et al.Differential expression of estrogen receptor alpha,beta1,and beta2 in lobular and ductal breast cancer[J].Proc Natl Acad Sci,2014,111(5):1933-1938.
[13] COUSE J F,KORACH K S.Estrogen receptor null mice:what have we learned and where will they lead us?[J].Endocr Rev,1999,20(3):358-417.
[14] DROOG M,BEELEN K,LINN S,et al.Tamoxifen resistance:from bench to bedside[J].Eur J Pharmacol,2013,717(1-3):47-57.
[15] FORSTER C,MAKELA S,WARRI A,et al.Involvement of estrogen receptor beta in terminal differentiation of mammary gland epithelium[J].Proc Natl Acad Sci,2002,99(24):15578-15583.
[16] ZHAO C,LAM E W,SUNTERS A,et al.Expression of estrogen receptor beta isoforms in normal breast epithelial cells and breast cancer:regulation by methylation[J].Oncogene,2003,22(48):7600-7606.
[17] TREECK O,JUHASZ-BOESS I,LATTRICH C,et al.Effects of exon-deleted estrogen receptor beta transcript variants on growth,apoptosis and gene expression of human breast cancer cell lines[J].Breast Cancer Res Treat,2008,110(3):507-520.
[18] 孟超.雌激素受体阴性乳腺癌的耐药机制和治疗的研究进展[J].东南大学学报:医学版,2012,31(4):523-525.
[19] COTRIM C Z,FABRIS V,DORIA M L,et al.Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells[J].Oncogene,2013,32(19):2390-2402.
[20] SPEIRS V,MALONE C,WALTON D S,et al.Increased expression of estrogen receptor beta mRNA in tamoxifen-resistant breast cancer patients[J].Cancer Res,1999,59(21):5421-5424.
[21] MARKEY G C,CULLEN R,DIGGIN P,et al.Estrogen receptor-beta mRNA is associated with adverse outcome in patients with breast cancer[J].Tumour Biol,2009,30(4):171-155.
[22] O'NEILL P A,DAVIES M P,SHAABAN A M,et al.Wild-type oestrogen receptor beta(ERbeta1) mRNA and protein expression in Tamoxifen-treated post-menopausal breast cancers[J].Br J Cancer,2004,91(9):1694-1702.
[23] 刘梦娜,谢静燕,赵树立.雌激素受体在卵巢癌研究中的进展[J].东南大学学报:医学版,2014,33(2):215-218.
[24] LI S,LI Y,WEN Z,et al.microRNA-206 overexpression inhibits cellular proliferation and invasion of estrogen receptor alpha-positive ovarian cancer cells[J].Mol Med Rep,2014,9(5):1703-1708.
[25] QIU J J,YE L C,DING J X,et al.Expression and clinical significance of estrogen-regulated long non-coding RNAs in estrogen receptor alpha-positive ovarian cancer progression[J].Oncol Rep,2014,31(4):1613-1622.
[26] CHAN K K,LEUNG T H,CHAN D W,et al.Targeting estrogen receptor subtypes(ERalpha and ERbeta) with selective ER modulators in ovarian cancer[J].J Endocrinol,2014,221(2):325-336.
[27] De STEFANO I,ZANNONI G F,PRISCO M G,et al.Cytoplasmic expression of estrogen receptor beta(ERbeta) predicts poor clinical outcome in advanced serous ovarian cancer[J].Gynecol Oncol,2011,122(3):573-579.
[28] CIUCCI A,ZANNONI G F,TRAVAGLIA D,et al.Prognostic significance of the estrogen receptor beta(ERbeta) isoforms ERbeta1,ERbeta2,and ERbeta5 in advanced serous ovarian cancer[J].Gynecol Oncol,2014,132(2):351-359.
[29] OMOTO Y,IMAMOV O,WARNER M,et al.Estrogen receptor alpha and imprinting of the neonatal mouse ventral prostate by estrogen[J].Proc Natl Acad Sci,2005,102(5):1484-1489.
[30] RICKE W A,MCPHERSON S J,BIANCO J J,et al.Prostatic hormonal carcinogenesis is mediated by in situ estrogen production and estrogen receptor alpha signaling[J].FASEB J, 2008,22(5):1512-1520.
[31] NOJIMA D,LI L C,DHARIA A,et al.CpG hypermethylation of the promoter region inactivates the estrogen receptor-beta gene in patients with prostate carcinoma[J].Cancer,2001,92(8):2076-2083.
[32] WALTON T J,LI G,SETH R,et al.DNA demethylation and histone deacetylation inhibition co-operate to re-express estrogen receptor beta and induce apoptosis in prostate cancer cell-lines[J].Prostate,2008,68(2):210-222.
[33] PRICE D,STEIN B,SIEBER P,et al.Toremifene for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia:results of a double-blind,placebo controlled,phase ⅡB clinical trial[J].J Urol,2006,176(3):965-970.
[34] KIM I Y,KIM B C,SEONG D H,et al.Raloxifene,a mixed estrogen agonist/antagonist,induces apoptosis in androgenindependent human prostate cancer cell lines[J].Cancer Res,2002,62(18):5365-5369.
[35] NEUBAUER B L,BEST K L,COUNTS D F,et al.Raloxifene(LY156758) produces antimetastatic responses and extends survival in the PAⅢ rat prostatic adenocarcinoma model[J].Prostate,1995,27(4):220-229.
[36] HORVATH L G,HENSHALL S M,LEE C S,et al.Frequent loss of estrogen receptor-beta expression in prostate cancer[J].Cancer Res,2001,61(14):5331-5335.
[37] GIROUX V,BERNATCHEZ G,CARRIER J C.Chemopreventive effect of ERbeta-selective agonist on intestinal tumorigenesis in Apc(Min/þ)mice[J].Mol Carcinog,2011,50(5):359-369.
[38] EDVARDSSON K,STROM A,JONSSON P,et al.Estrogen receptor beta induces antiinflammatory and antitumorigenic networks in colon cancer cells[J].Mol Endocrinol,2011,25(6):969-979.
[39] EDVARDSSON K,NGUYEN-VU T,KALASEKAR S M,et al.Estrogen receptor beta expression induces changes in the microRNA pool in human colon cancer cells[J].Carcinogenesis,2013,34(7):1431-1441. |
